The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Can Type 1 Diabetics Take Mounjaro For Weight Loss?
Type 1 diabetics can potentially take Mounjaro (tirzepatide) for weight loss, but it requires careful medical assessment and monitoring. Unlike type 2 diabetes, type 1 involves an autoimmune condition where the pancreas doesn't produce insulin. Mounjaro may complicate insulin management, increase hypoglycaemia risk, and requires specialist oversight. Your GP or diabetes consultant will assess whether this weekly weight loss injection is suitable for your individual health profile, existing insulin regimen, and blood sugar control before prescribing.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Type 1 Diabetes and Mounjaro — Key Safety Considerations
Mounjaro works as a dual GIP and GLP-1 receptor agonist, helping regulate appetite and blood sugar levels. However, for type 1 diabetics, this creates a significant interaction with insulin therapy. Mounjaro slows gastric emptying and may reduce food intake substantially, which can trigger hypoglycaemia (low blood sugar) if insulin doses are not carefully adjusted. Type 1 diabetics require intensive insulin management — any weight loss medication changes the carbohydrate intake and absorption patterns, meaning insulin requirements often decrease significantly.
- Increased hypoglycaemia risk if insulin doses are not reduced
- Need for frequent blood glucose monitoring and insulin adjustment
- Potential interaction with continuous glucose monitoring (CGM) data interpretation
- Requires diabetes specialist involvement, not GP-only prescription
For these reasons, Mounjaro in type 1 diabetes is typically only prescribed through specialist tier 3 or tier 4 NHS weight management services working alongside your diabetes team, not through routine private online prescribing routes.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Accessing Mounjaro As A Type 1 Diabetic — NHS and Private Routes
NHS route: Referral to a specialist weight management service (tier 3 or 4) that can coordinate with your diabetes clinic. This ensures insulin adjustments are managed safely. Waiting lists vary by region and can be lengthy; some areas have better integrated pathways.
Private route: Most private online prescribers require additional safety checks for type 1 diabetics and may decline to prescribe without direct liaison with your diabetes consultant. Private costs typically range from £129–£320 monthly depending on your dose titration stage, but access is more restrictive for type 1 cases. Always disclose type 1 diabetes during any online consultation.
Both routes require you to monitor blood glucose more frequently during the initial weeks and schedule regular follow-up appointments. Use our free BMI calculator and GLP-1 weight loss calculator to understand your current health metrics before seeking assessment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro safe for type 1 diabetics?
Mounjaro can be used in type 1 diabetes but requires careful medical management. The main risk is hypoglycaemia if insulin doses aren't adjusted as appetite and food intake change. It must be prescribed and monitored by a specialist diabetes team, not as a standalone weight loss injection. Safety depends entirely on coordinated insulin management.
Will Mounjaro lower my insulin requirements?
Yes, likely. As Mounjaro reduces appetite and food intake, your insulin needs typically decrease. This requires close blood glucose monitoring and regular insulin dose adjustments with your diabetes clinic. Some type 1 diabetics reduce insulin by 20–40%, but this is individual and must be guided by your team, not self-adjusted.
Can I get Mounjaro on the NHS with type 1 diabetes?
Potentially, through a specialist tier 3 or 4 weight management service coordinating with your diabetes clinic. NHS availability varies significantly by region. You'll need a GP referral, and the service must have protocols for managing type 1 diabetes safely. Waiting lists can be very long in many areas.
What's the difference between Mounjaro and Wegovy for type 1 diabetics?
Both are weekly weight loss injections affecting blood sugar, but Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist while Wegovy (semaglutide) is a GLP-1 agonist only. Neither is routinely prescribed for type 1 outside specialist services. Mounjaro may carry slightly higher hypoglycaemia risk due to its dual mechanism, but both require specialist oversight.
How often will I need blood glucose monitoring?
During initial weeks, more frequent monitoring (4–6 times daily or continuous glucose monitor review) is essential to adjust insulin safely. Once stable on Mounjaro, monitoring frequency depends on your individual regimen but remains more intensive than pre-medication baseline. Your diabetes team will set a specific protocol.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.